New report says remote inspections of clinical trial sites will continue but not completely replace in-person efforts in a post-COVID-19 era.
Thoroughly addressing behind-the-scenes minutiae is the key to a smooth working relationship between study sites and IRBs, expert says.
A new regulation aims to ensure that the European Union offers an “attractive and favorable environment” for high-quality clinical research.
The pandemic may have spurred big changes in clinical trial design and conduct, but an FDA official says the key to prepping for an agency inspection remains the same.
Finding the right balance of information to send to IRBs during remote trials is a delicate, but crucial, challenge, experts say.